Le Lézard
Classified in: Business
Subject: STH

IIROC Trading Halt - RDS


VANCOUVER, Nov. 16, 2018 /CNW/ - The following issues have been halted by IIROC:

Company: Radisson Mining Resources Inc.

TSX-Venture Symbol: RDS

Reason: At the Request of the Company Pending News

Halt Time (ET): 12:20 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 12:00
Pomerantz LLP is investigating claims on behalf of investors of Li Auto Inc. ("Li Auto" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 12:00
Ralph & Pat Plumb, owners of the Brick Alley Pub, announced today that they've entered into an agreement to sell the Brick Alley Pub to The Heritage Restaurant Group, formerly 1899 Ventures, a Newport Rhode Island based restaurant group. The Brick...

at 12:00
Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation ("SeaStar" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 12:00
Pomerantz LLP is investigating claims on behalf of investors of Perion Network Ltd. ("Perion" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 12:00
Pomerantz LLP is investigating claims on behalf of investors of TMC the metals company Inc. ("TMC" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. ...

at 12:00
Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. ("Zevra" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....



News published on and distributed by: